Open AccessFC032: Copeptin as a Potential Biomarker in Patients with Autosomal-Dominant Polycystic Kidney Disease (ADPKD)—Update from the AD(H)PKD Study
Author(s) -
Simon Oehm,
Sita Arjune,
Philipp Antczak,
Polina Todorova,
Franziska Grundmann,
Roman-Ulrich Mueller
Publication year - 2022
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfac101.004
Subject(s) - copeptin , medicine , autosomal dominant polycystic kidney disease , tolvaptan , biomarker , creatinine , polycystic kidney disease , urology , kidney disease , oncology , endocrinology , disease , vasopressin , biochemistry , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom